| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE 1.5 MG | 1224 |
| 1 | DEXAMETHASONE | 1223 |
| 2 | CYCLOPHOSPHAMIDE | 1219 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 1219 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 1219 |
| 5 | CARBOPLATIN | 942 |
| 6 | RITUXIMAB | 786 |
| 7 | ETOPOSIDE | 744 |
| 8 | DOXORUBICIN | 659 |
| 9 | CISPLATIN | 644 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEMECLOCYCLINE | 10 | 0.0439 |
| 1 | IBERDOMIDE | 4 | 0.0268 |
| 2 | PEGFILGRASTIM | 258 | 0.0215 |
| 3 | PRALATREXATE | 14 | 0.0215 |
| 4 | VINORELBINE | 141 | 0.0202 |
| 5 | POTASSIUM BICARBONATE | 12 | 0.0166 |
| 6 | CLOFARABINE | 34 | 0.0149 |
| 7 | CHLORAMBUCIL | 55 | 0.0140 |
| 8 | EPHEDRINE HYDROCHLORIDE | 6 | 0.0132 |
| 9 | GLASDEGIB | 6 | 0.0127 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 2259 |
| 1 | Platinum-based Drug [EPC] | 1741 |
| 2 | Alkylating Drug [EPC] | 1573 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 1309 |
| 4 | Proton Pump Inhibitor [EPC] | 1035 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 945 |
| 6 | Microtubule Inhibitor [EPC] | 832 |
| 7 | Topoisomerase Inhibitor [EPC] | 761 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 700 |
| 9 | Leukocyte Growth Factor [EPC] | 663 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 81 | 0.0138 |
| 1 | CD33-directed Immunoconjugate [EPC] | 43 | 0.0117 |
| 2 | Actinomycin [EPC] | 23 | 0.0104 |
| 3 | Anthracycline Topoisomerase Inhibitor [EPC] | 25 | 0.0103 |
| 4 | Topoisomerase Inhibitor [EPC] | 761 | 0.0099 |
| 5 | Macrolide Antibacterial [EPC] | 9 | 0.0089 |
| 6 | Lymphocyte Growth Factor [EPC] | 11 | 0.0087 |
| 7 | CD22-directed Immunoconjugate [EPC] | 23 | 0.0077 |
| 8 | Alkylating Drug [EPC] | 1573 | 0.0064 |
| 9 | Platinum-based Drug [EPC] | 1741 | 0.0064 |